UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry

Arthritis and rheumatism, 2010-09, Vol.62 (9), p.2625-2632

2010

Volltextzugriff (PDF)

Leflunomide-induced subacute cutaneous lupus erythematosus

Rheumatology (Oxford, England), 2005-06, Vol.44 (6), p.823-824

2005

Volltextzugriff (PDF)

IgM anti‐myeloperoxidase antibody‐secreting lymphocytes are present in the peripheral repertoire of lupus mice but rarely differentiate into IgG‐producing cells

Clinical and experimental immunology, 1999-10, Vol.118 (1), p.122-130

1999

Volltextzugriff (PDF)

Bon usage du rituximab : bilan régional sur un an

La revue de medecine interne, 2012-12, Vol.33, p.A134-A134

2012

Volltextzugriff (PDF)

Analysis of T cell receptors in rheumatoid arthritis: the increased expression of HLA‐DR antigen on circulating γδ+ T cells is correlated with disease activity

Clinical and experimental immunology, 2008-06, Vol.89 (2), p.217-222

2008

Volltextzugriff (PDF)

Analyse des prescriptions de rituximab en Haute-Normandie

La revue de medecine interne, 2011-12, Vol.32, p.S374-S374

2011

Volltextzugriff (PDF)

Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey

Arthritis research & therapy, 2005-01, Vol.7 (3), p.R545-R551, Article R545

2005

Volltextzugriff (PDF)

Anti-TNF-alpha-induced systemic lupus syndrome

Clinical rheumatology, 2003-02, Vol.22 (1), p.56

2003

Volltextzugriff (PDF)

Vertebral hyperostosis and diabetes mellitus: a case-control study

Annals of the rheumatic diseases, 1995-05, Vol.54 (5), p.375-378

1995

Volltextzugriff (PDF)

Association between -871C>T promoter polymorphism in the B-cell activating factor gene and the response to rituximab in rheumatoid arthritis patients

Rheumatology (Oxford, England), 2013-04, Vol.52 (4), p.636-641

2013

Volltextzugriff (PDF)

Autoantibodies to the 27 C‐terminal amino acids of calpastatin are detected in a restricted set of connective tissue diseases and may be useful for diagnosis of rheumatoid arthritis in community cases of very early arthritis

Rheumatology (Oxford, England), 2001-10, Vol.40 (10), p.1126-1134

2001

Volltextzugriff (PDF)

Comparative study of 6 types of criteria in adult Still's disease

Journal of rheumatology, 1996-03, Vol.23 (3), p.495

1996

Volltextzugriff (PDF)

Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes

Arthritis research & therapy, 2009-01, Vol.11 (2), p.R38-R38

2009

Volltextzugriff (PDF)

Identification of secreted phosphoprotein 1 gene as a new rheumatoid arthritis susceptibility gene

Annals of the rheumatic diseases, 2015-03, Vol.74 (3), p.e19-e19

2015

Volltextzugriff (PDF)

Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study

Rheumatology, 2009-07, Vol.48 (7), p.761-764

2009

Volltextzugriff (PDF)

Level of agreement of the 1987 ACR and 2010 ACR/EULAR rheumatoid arthritis classification criteria: an analysis based on ESPOIR cohort data

Annals of the rheumatic diseases, 2012-03, Vol.71 (3), p.386-389

2012

Volltextzugriff (PDF)

Influence of gender on response to rituximab in patients with rheumatoid arthritis: results from the Autoimmunity and Rituximab registry

Rheumatology (Oxford, England), 2014-10, Vol.53 (10), p.1788-1793

2014

Volltextzugriff (PDF)

Musculoskeletal ultrasonography in healthy subjects and ultrasound criteria for early arthritis (the ESPOIR cohort)

Journal of rheumatology, 2011-04, Vol.38 (4), p.613-620

2011

Volltextzugriff (PDF)

OP0237 Polymorphisms of Gene Implicated in Type 1 Interferon Pathway Are Associated with The Clinical Response of Rituximab at 24 Weeks in Rheumatoid Arthritis

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.147-148

2016

Volltextzugriff (PDF)

Health‐care use by rheumatoid arthritis patients compared with non‐arthritic subjects

British journal of rheumatology, 2002-02, Vol.41 (2), p.167-175

2002

Volltextzugriff (PDF)

Administation des biothérapies : un audit du parcours du patient entre la ville et l'hôpital. Étude QualiRhumato

Revue du rhumatisme (Ed. française : 1993), 2007-11, Vol.74 (10-11), p.1036-1036

2007

Volltextzugriff (PDF)

Vasculite avec ulcérations cutanées au cours de la polyarthrite rhumatoïde : traitement par anti TNFδ

Annales de dermatologie et de vénéréologie, 2006-05, Vol.133 (5), p.453-455

2006

Volltextzugriff (PDF)

Local and systemic activation of the whole complement cascade in human leukocytoclastic cutaneous vasculitis; C3d,g and terminal complement complex as sensitive markers

Clinical and experimental immunology, 1993-05, Vol.92 (2), p.274-283

1993

Volltextzugriff (PDF)

Prospective evaluation of the frequency and clinical significance of antineutrophil cytoplasmic and anticardiolipin antibodies in community cases of patients with rheumatoid arthritis

Rheumatology (Oxford, England), 2000-05, Vol.39 (5), p.481-489

2000

Volltextzugriff (PDF)

THU0087 One single infusion of rituximab 1g might be sufficient in the long-term management of rheumatoid arthritis patients responding to a first cycle of rituximab (2 × 1g): Results of a 2-year multi-center randomized controlled trial

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.182-182

2013

Volltextzugriff (PDF)

26 – 50 von 337

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(181)
Mit Volltextzugriff
(178)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(180)
Female
(115)
Male
(107)
Life Sciences & Biomedicine
(103)
Middle Aged
(103)
Science & Technology
(103)
Adult
(80)
Aged
(76)
Rheumatology
(70)
Biological And Medical Sciences
(57)
Medical Sciences
(57)
Rheumatoid Arthritis
(37)
Diseases Of The Osteoarticular System
(31)
Sciences Biologiques Et Medicales
(29)
Sciences Medicales
(29)
Inflammatory Joint Diseases
(27)
Arthritis, Rheumatoid - Drug Therapy
(23)
Prospective Studies
(23)
Treatment Outcome
(21)
Pharmacology. Drug Treatments
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry

Leflunomide-induced subacute cutaneous lupus erythematosus

IgM anti‐myeloperoxidase antibody‐secreting lymphocytes are present in the peripheral repertoire of lupus mice but rarely differentiate into IgG‐producing cells

Bon usage du rituximab : bilan régional sur un an

Analysis of T cell receptors in rheumatoid arthritis: the increased expression of HLA‐DR antigen on circulating γδ+ T cells is correlated with disease activity

Analyse des prescriptions de rituximab en Haute-Normandie

Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey

Anti-TNF-alpha-induced systemic lupus syndrome

Vertebral hyperostosis and diabetes mellitus: a case-control study

Association between -871C>T promoter polymorphism in the B-cell activating factor gene and the response to rituximab in rheumatoid arthritis patients

Autoantibodies to the 27 C‐terminal amino acids of calpastatin are detected in a restricted set of connective tissue diseases and may be useful for diagnosis of rheumatoid arthritis in community cases of very early arthritis

Comparative study of 6 types of criteria in adult Still's disease

Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes

Identification of secreted phosphoprotein 1 gene as a new rheumatoid arthritis susceptibility gene

Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study

Level of agreement of the 1987 ACR and 2010 ACR/EULAR rheumatoid arthritis classification criteria: an analysis based on ESPOIR cohort data

Influence of gender on response to rituximab in patients with rheumatoid arthritis: results from the Autoimmunity and Rituximab registry

Musculoskeletal ultrasonography in healthy subjects and ultrasound criteria for early arthritis (the ESPOIR cohort)

OP0237 Polymorphisms of Gene Implicated in Type 1 Interferon Pathway Are Associated with The Clinical Response of Rituximab at 24 Weeks in Rheumatoid Arthritis

Health‐care use by rheumatoid arthritis patients compared with non‐arthritic subjects

Administation des biothérapies : un audit du parcours du patient entre la ville et l'hôpital. Étude QualiRhumato

Vasculite avec ulcérations cutanées au cours de la polyarthrite rhumatoïde : traitement par anti TNFδ

Local and systemic activation of the whole complement cascade in human leukocytoclastic cutaneous vasculitis; C3d,g and terminal complement complex as sensitive markers

Prospective evaluation of the frequency and clinical significance of antineutrophil cytoplasmic and anticardiolipin antibodies in community cases of patients with rheumatoid arthritis

THU0087 One single infusion of rituximab 1g might be sufficient in the long-term management of rheumatoid arthritis patients responding to a first cycle of rituximab (2 × 1g): Results of a 2-year multi-center randomized controlled trial

Suchergebnisse filtern